日本語 >>
TOP page
Journal
Presentation
(Last updated : 2021-07-28 16:03:56)
羽井佐 実
Department
,
Position
■
Journal
1.
2017/11
Targeted silencing of SOX2 by an artificial transcription factor showed antitumor effect in lung and esophageal squamous cell carcinoma.
2.
2017/10
Targeted silencing of SOX2 by an artificial transcription factor showed antitumor effect in lung and esophageal squamous cell carcinoma.
3.
2017/04
False-Positive Cases of Fluorodeoxyglucose-Positron Emission Tomography/Computed Tomographic Scans in Metastasis of Esophageal Cancer
4.
2017/02
A Case of Cholesterol Crystal Embolization with Hemorrhagic Imntestinal Ulcer
5.
2017/02
Evaluation of intra-ductal cancer spread using contrast superb micro-vascular imaging(SMI)-a case report-
6.
2016/02
SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma
7.
2015/06
Skin Tube Reconstruction for Esophageal Defects due to Postoperative Complications: Applying a skin flap in esophageal
resection and reconstruction
8.
2015/05
Feasibility of oral administration of S-1 as adjuvant chemotherapy in gastric cancer: 4-week S-1 administration followed by 2-week rest vs. 2-week administration followed by 1-week rest
9.
2014/12
A case report of isolated presacral squamous cell carcinoma developd four years after gastrectomy
10.
2014/12
Amino acid signaling in the intestine: The roles of glutamine, leucine and arginine
11.
2013/04
The type 1 insulin-like growth factor receptor signalling system and targeted tyrosine kinase inhibition in cancer.
Display 5 items
Display all(11)
■
Presentation
1.
2018/09/28
Targeted silencing of SOX2 by an ATF showed antitumor effect in lung and esophageal squamous cell carcinoma
2.
2018/09/16
False positive cases of FDG-PET/CT in metastasis of esophageal squamous cell carcinoma
3.
2018/06/08
A surgical case of jejunal aberrant pancreas containing high-grade pancreatic intraepithelial neoplasia(PanIN3)
4.
2018/04/16
Targeted silencing of SOX2 by an artificial transcription factor showed antitumor effect in lung and esophageal squamous cell carcinoma
5.
2017/06/09
A surgical case of metachronous liver metastasis of hepatoid adenocarcinoma of the stomach
6.
2017/04/03
Development of a novel targeted therapy for malignant mesothelioma carcinoma by a midkine inhibitor.
7.
2016/10/06
SOX2 suppresses CDKN1A to sustain growth of lung squamous cell carcinoma
8.
2016/04/18
Sox2 silencing upregulates CDKNIA and suppresses growth of lung squamous cell carcinoma
9.
2015/04/21
Developmemt of a Sox2 targeting therapy for the treatment of lung squamous cell carcinoma
10.
2015/04/20
Esphageal cancer exhibits a resistance to the chemical of IGF-1R with a maintained Ras-MAPK activity
11.
2014/09/27
Sox2 silencing suppresses cell growth and colony formation of
squamous cell lung cancer
12.
2014/04/06
Effective use of MDK/Midkine and MEK inhibitor to treat KRas mutated pulmonary adenocarcinoma cells
13.
2014/04/04
Inhibition of the growth factor midkine by a novel small molecule compound to treat pulmonary adenocarcinoma
14.
2010/09/01
Analysis of Surgically Resected Case of Barrett's ESophageal Carcinoma.
15.
2010/04/19
N-cadherin down-rgulation has antitumor effects in esophageal cancer
Display 5 items
Display all(15)